Hippocampal-Sparing Stereotactic Radiosurgery Treatment of Brain Metastases Using CyberKnife

PHASE2UnknownINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

December 30, 2023

Study Completion Date

December 30, 2024

Conditions
Brain MetastasesRadiosurgery
Interventions
RADIATION

Hippocampal-sparing

Dose constraint placed on hippocampi to minimize dose to hippocampi, while maintaining target coverage (at least 98% of brain metastasis volume must receive 100% of prescription dose).

RADIATION

Stereotactic radiosurgery

Stereotactic radiosurgery (SRS) with prescription dose determined based on size of brain metastasis; 21 or 24 Gy in a single fraction if less than or equal to 20 mm, 18Gy in a single fraction in 21 - 30 mm, 15 Gy in a single fraction or 30 Gy in 5 fractions if 31 - 40 mm (physician discretion).

All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER